Post Traumatic Stress Disorder Market on Track for Major Expansion by 2034, According to DelveInsight | Pfizer, GlaxoSmithKline, KGK Science Inc., AstraZeneca, UCB Pharma, Bionorica SE, Bionomics Limited

DelveInsight's "Post Traumatic Stress Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Post Traumatic Stress Disorder, historical and forecasted epidemiology as well as the Post Traumatic Stress Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Post Traumatic Stress Disorder market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Post Traumatic Stress Disorder Market Forecast
https://www.delveinsight.com/sample-request/post-traumatic-stress-disorder-ptsd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Post Traumatic Stress Disorder Market Report:
• The Post Traumatic Stress Disorder market size was valued ~USD 1,760 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In November 2023, Silo Pharma has secured an exclusive license agreement with Medspray Pharma BV for intranasal technology utilized in the SPC-15 treatment targeting PTSD.
• In September 2023, The US FDA reported favorable initial findings from its Phase IIb ATTUNE trial evaluating BNC210 for PTSD treatment.
• In 2023, there were approximately 13.8 million prevalent cases of PTSD across the 7MM. These numbers are projected to rise in the forecasted period. The highest prevalence of PTSD cases was noted in the United States.
• In the EU4 countries and the UK, there were approximately 3.387 million prevalent cases of PTSD in 2023, with expectations for an increase in the forecasted period.
• In 2023, there were around 4.201 million cases of PTSD among males and approximately 9.6 million cases among females across the 7MM.
• In 2023, PTSD cases were categorized by severity as approximately 4.43 million cases for mild, around 4.36 million cases for moderate, and about 5 million cases for severe across the 7MM.
• In 2023, the total number of treated PTSD cases was approximately 2.5 million across the 7MM, with expectations for an increase during the forecast period.
• Key Post Traumatic Stress Disorder Companies: Nobilis Therapeutics, Otsuka Pharma, Compass Pathways, Aptinyx, Jazz Pharmaceuticals, COMPASS Pathways, Bionomics Limited, Boehringer Ingelheim, GlaxoSmithKline, KGK Science Inc., AstraZeneca, UCB Pharma, Bionorica SE, Bionomics Limited, Pfizer, and others
• Key Post Traumatic Stress Disorder Therapies: REXULTI ± ZOLOFT, NBTX001, Brexpiprazole, COMP360, NYX-783, JZP150, Psilocybin, BNC210, BI 1358894, orvepitant, Psilocybin, Quetiapine Fumarate, levetiracetam, BX-1, BNC210, Ziprasidone, and others
• The Post Traumatic Stress Disorder epidemiology based on gender analyzed that females are more affected with PTSD than females
• The Post Traumatic Stress Disorder market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Post Traumatic Stress Disorder pipeline products will significantly revolutionize the Post Traumatic Stress Disorder market dynamics.

Post Traumatic Stress Disorder Overview
Post-Traumatic Stress Disorder (PTSD) is a mental health condition that can develop after an individual has been exposed to a traumatic event. These events may include experiencing or witnessing situations such as natural disasters, serious accidents, terrorist attacks, war/combat, rape, or other forms of physical, sexual, or emotional abuse.

Get a Free sample for the Post Traumatic Stress Disorder Market Report -
https://www.delveinsight.com/report-store/post-traumatic-stress-disorder-ptsd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Post Traumatic Stress Disorder Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Post Traumatic Stress Disorder Epidemiology Segmentation:
The Post Traumatic Stress Disorder market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Post Traumatic Stress Disorder
• Prevalent Cases of Post Traumatic Stress Disorder by severity
• Gender-specific Prevalence of Post Traumatic Stress Disorder
• Diagnosed Cases of Episodic and Chronic Post Traumatic Stress Disorder

Download the report to understand which factors are driving Post Traumatic Stress Disorder epidemiology trends @ Post Traumatic Stress Disorder Epidemiology Forecast
https://www.delveinsight.com/sample-request/post-traumatic-stress-disorder-ptsd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Post Traumatic Stress Disorder Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Post Traumatic Stress Disorder market or expected to get launched during the study period. The analysis covers Post Traumatic Stress Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Post Traumatic Stress Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Post Traumatic Stress Disorder Therapies and Key Companies
• REXULTI ± ZOLOFT: Otsuka Pharmaceutical
• NBTX001: Nobilis Therapeutics
• Brexpiprazole: Otsuka Pharma
• COMP360: Compass Pathways
• NYX-783: Aptinyx
• JZP150: Jazz Pharmaceuticals
• Psilocybin: COMPASS Pathways
• BNC210: Bionomics Limited
• BI 1358894: Boehringer Ingelheim
• orvepitant: GlaxoSmithKline
• Psilocybin: KGK Science Inc.
• Quetiapine Fumarate: AstraZeneca
• levetiracetam: UCB Pharma
• BX-1: Bionorica SE
• Ziprasidone: Pfizer

Discover more about therapies set to grab major Post Traumatic Stress Disorder market share @ Post Traumatic Stress Disorder Treatment Market
https://www.delveinsight.com/sample-request/post-traumatic-stress-disorder-ptsd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Post Traumatic Stress Disorder Market Strengths
• New diagnostic categories modeled on PTSD have been proposed, including prolonged duress stress disorder, post-traumatic grief disorder, post-traumatic relationship syndrome, post-traumatic dental care anxiety, and post-traumatic abortion syndrome.

Post Traumatic Stress Disorder Market Opportunities
• The introduction of novel drugs and the class of new therapeutic drugs to treat PTSD in the market will bring hope to the PTSD patients as a therapeutic option and might have a major positive effect on the market.

Scope of the Post Traumatic Stress Disorder Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Post Traumatic Stress Disorder Companies: Nobilis Therapeutics, Otsuka Pharma, Compass Pathways, Aptinyx, Jazz Pharmaceuticals, COMPASS Pathways, Bionomics Limited, Boehringer Ingelheim, GlaxoSmithKline, KGK Science Inc., AstraZeneca, UCB Pharma, Bionorica SE, Bionomics Limited, Pfizer, and others
• Key Post Traumatic Stress Disorder Therapies: REXULTI ± ZOLOFT, NBTX001, Brexpiprazole, COMP360, NYX-783, JZP150, Psilocybin, BNC210, BI 1358894, orvepitant, Psilocybin, Quetiapine Fumarate, levetiracetam, BX-1, BNC210, Ziprasidone, and others
• Post Traumatic Stress Disorder Therapeutic Assessment: Post Traumatic Stress Disorder current marketed and Post Traumatic Stress Disorder emerging therapies
• Post Traumatic Stress Disorder Market Dynamics: Post Traumatic Stress Disorder market drivers and Post Traumatic Stress Disorder market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Post Traumatic Stress Disorder Unmet Needs, KOL's views, Analyst's views, Post Traumatic Stress Disorder Market Access and Reimbursement

To know more about Post Traumatic Stress Disorder companies working in the treatment market, visit @ Post Traumatic Stress Disorder Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/post-traumatic-stress-disorder-ptsd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Post Traumatic Stress Disorder Market Report Introduction
2. Executive Summary for Post Traumatic Stress Disorder
3. SWOT analysis of Post Traumatic Stress Disorder
4. Post Traumatic Stress Disorder Patient Share (%) Overview at a Glance
5. Post Traumatic Stress Disorder Market Overview at a Glance
6. Post Traumatic Stress Disorder Disease Background and Overview
7. Post Traumatic Stress Disorder Epidemiology and Patient Population
8. Country-Specific Patient Population of Post Traumatic Stress Disorder
9. Post Traumatic Stress Disorder Current Treatment and Medical Practices
10. Post Traumatic Stress Disorder Unmet Needs
11. Post Traumatic Stress Disorder Emerging Therapies
12. Post Traumatic Stress Disorder Market Outlook
13. Country-Wise Post Traumatic Stress Disorder Market Analysis (2020-2034)
14. Post Traumatic Stress Disorder Market Access and Reimbursement of Therapies
15. Post Traumatic Stress Disorder Market Drivers
16. Post Traumatic Stress Disorder Market Barriers
17. Post Traumatic Stress Disorder Appendix
18. Post Traumatic Stress Disorder Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Post Traumatic Stress Disorder Pipeline https://www.delveinsight.com/report-store/post-traumatic-stress-disorder-ptsd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Post Traumatic Stress Disorder Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Post Traumatic Stress Disorder market. A detailed picture of the Post Traumatic Stress Disorder pipeline landscape is provided, which includes the disease overview and Post Traumatic Stress Disorder treatment guidelines.

Post Traumatic Stress Disorder Epidemiology https://www.delveinsight.com/report-store/post-traumatic-stress-disorder-ptsd-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Post Traumatic Stress Disorder Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Post Traumatic Stress Disorder epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Papilloma Market
https://www.delveinsight.com/report-store/papilloma-market
DelveInsight's "Papilloma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Papilloma, historical and forecasted epidemiology as well as the Papilloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Periodontal Disease Market
https://www.delveinsight.com/report-store/periodontal-disease-market
DelveInsight's "Periodontal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
DelveInsight's 'Resorbable Vascular Scaffolds - Market Insight, Competitive Landscape, and Market Forecast - 2030' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Retinoblastoma Market
https://www.delveinsight.com/report-store/retinoblastoma-market
DelveInsight's "Retinoblastoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Retinoblastoma, historical and forecasted epidemiology as well as the Retinoblastoma market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Sickle Cell Disease Market
https://www.delveinsight.com/report-store/sickle-cell-disease-6mm-market
DelveInsight's "Skin Burns Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Skin Burns, historical and forecasted epidemiology as well as the Skin Burns market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom).

Skin Burns Market
https://www.delveinsight.com/report-store/skin-burns-market
DelveInsight's "Skin Burns Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Skin Burns, historical and forecasted epidemiology as well as the Skin Burns market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market
DelveInsight's "Thymus Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Thymus Cancer, historical and forecasted epidemiology as well as the Thymus Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.